Prognostic significance of the loss of heterozygosity of nm23‐h1 and p53 genes in human colorectal carcinomas

Cancer

Volumn 73, Issue 12, 1994, Pages 2913-2921

  Campo, Elias ^a   Miquel, Rosa ^a   Jares, Pedro ^a   Bosch, Francesc ^a   Juan, Manel ^b   Leone, Alvaro ^c   Vives, Jordi ^b   Cardesa, Antonio ^a   Yague, Jordi ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

^c Istituto Oncologico   (Italy)

Author keywords

colorectal carcinoma; DNA ploidy; Nm23; p53; tumor suppressor genes

Indexed keywords

DNA; PROTEIN P53;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER SURVIVAL; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME LOSS; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; FLOW CYTOMETRY; GENE LOCATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS INHIBITION; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; ALLELES; ANEUPLOIDY; BASE SEQUENCE; BLOTTING, SOUTHERN; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; COLORECTAL NEOPLASMS; FEMALE; GENE DELETION; GENES, P53; HETEROZYGOTE; HUMAN; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTORS;

EID: 0028301964     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19940615)73:12<2913::AID-CNCR2820731207>3.0.CO;2-L     Document Type: Article

References (54)

1. A genetic model for colorectal tumorigenesis
2. Genetic alterations during colorectal‐tumor development
3. Evidence for a novel gene associated with low tumor metastatic potential
4. Reduced Nm23/Awd protein in tumor metastasis and aberrant Drosophila development
5. Identification of a second human nm23 gene, nm23‐H2
6. Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival
7. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential
8. Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis
9. Altered expression of nm23, a gene associated with low tumor metastatic potential, during adenovirus 2 E1a inhibition of experimental metastasis
10. Levels of nm23 RNA in metastatic malignant melanomas: inverse correlation to disease progression
11. Immunohistochemical analysis of nucleoside diphosphate kinase (or nm23 gene product) expression in human hepatocellular carcinoma
12. Reduced nm23‐H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid
13. Reduced tumor incidence, metastatic potential and cytokine responsive of nm23 transfected melanoma cells
14. Transfection of human nm23‐H1 into human MDA‐MB‐435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity
15. Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential
16. Association of nm23‐H1 allelic deletions with distant metastases in colorectal carcinomas
17. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
18. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas
19. Survival and acquired genetic alterations in colorectal carcinomas
20. The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma
21. Closing in on breast cancer gene on chromosome 17q
22. Report of the committee on the genetic constitution of chromosome 17
23. Primary structure polymorphism at amino acid residue 72 of human p53
24. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17
25. An MspI polymorphism for the HOX2F gene
26. Detection of specific sequences among DNA fragments separated by electrophoresis
27. AccII polymorphism of the p53
28. Method for analysis of cellular DNA content of paraffin‐embedded pathological material using flow cytometry
29. A detergent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysis
30. Convention on nomenclature for DNA cytometry
31. Non‐parametric estimation from incomplete observations
32. Evaluation of survival data and two new rank order statistics arising in its consideration
33. Bgl II and EcoRI polymorphisms of the human nm23‐H1 gene
34. Biallelic BgIII DNA polymorphisms of the human p53 oncogene
35. Somatic allelic deletion of nm23 in human cancer
36. Allelotype of colorectal carcinomas
37. The TP53 tumour supressor gene in colorectal carcinomas. I: genetic alterations on chromosome 17
38. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
39. Multiple genetic alterations in distal and proximal colorectal cancer
40. Allelic loss in colorectal carcinoma
41. Expression of p53 and 17p allelic loss in colorectal carcinoma
42. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis
43. Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas
44. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas
45. Mutation in the nm23 gene is associated with metastasis in colorectal cancer
46. Increased nm23‐H1 and nm23‐H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential
47. The influence of tumor cell DNA abnormalities on survival in colorectal cancer
48. Colorectal cancer: Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related tumor DNA ploidy pattern
49. Prognostic implications of proliferative activity and DNA aneuploidy in Astler‐Coller Dukes stage C colonic adenocarcinomas
50. Increased p53 protein content of colorectal tumours correlates with poor survival
51. The TP53 tumour supressor gene in colorectal carcinomas. II: relation to DNA ploidy pattern and clinicopathological variables